Neobiomics AB has always strived to reach new heights and with this in mind, we collaborated with ExCEEd Orphan to initiate the distribution of ProPrems® in the CEE region.
We are glad and thankful to everyone that has made this possible. Together with ExCEEd Orphan, we are very excited to announce the first sales in the Czech Republic and Hungary. With forward-thinking, we would like to continue to collaborate and to serve societal healthcare needs in the coming days.
About ExCEEd Orphan
ExCEEd Orphan focuses on innovative treatments for rare diseases and has extensive experience in launching innovative medicines in this field. The portfolio of ExCEEd Orphan includes products in therapeutic areas like hematology, neurology, immunology, and metabolic diseases. ExCEEd Orphan works towards maximising the availability of medications.